Biodesix, Inc. Company Profile

00:55 EDT 23rd March 2018 | BioPortfolio

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix provides physicians with tools for earlier disease detection, more accurate diagnosis, and better therapeutic guidance. In 2009, Biodesix launched VeriStrat®, a serum proteomic test that helps physicians guide treatment for patients with non-small cell lung cancer. VeriStrat is based on ProTS®, proprietary technology which harnesses the power of mass spectrometry and enables the discovery of specific molecular profiles that characterize a patient’s condition or likely outcome in response to therapy. The ProTS® platform has broad application and provides the foundation for collaborations with leading researchers as well as partnerships with biotechnology and pharmaceutical companies seeking to develop companion diagnostics and improve the targeting of their therapies. For more information about Biodesix, please visit the Company’s website at

News Articles [13 Associated News Articles listed on BioPortfolio]

Biodesix To Present Data at SITC Annual Meeting

BOULDER, Colo., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Biodesix will conduct an oral presentation on immunotherapy biomarkers in addition to presenting data from two separate studies at the SITC 2017 ...

Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix® announced a new collaboration agreement with PD-L1 expert Professor Fred R. Hirsch, MD, PhD, laboratory director at the Hirsch Biomark...

Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals

BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate Pharmaceut...

MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Scienc...

Biodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with Immunohistochemistry

BOULDER, Colo., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Biodesix® presented preliminary data evaluating a blood-based PD-L1 assay to identify patients who may benefit from cancer immunotherapies. The ...

Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners

BOULDER, Colo., March 05, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc., a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology, today ...

Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress

BOULDER, Colo., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Biodesix provided updates and data related to the company’s on-market and in-development liquid biopsy tests at the 2017 qPCR & Digital PCR...

Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix® chief technology officer, Dr. Heinrich Roder, will give an oral presentation discussing a proprietary test development methodology tha...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Biodesix Inc.

Biodesix is a personalized medicine company focused on the development of diagnostic products that inform treatment decisions and improve patient care. In 2009, Biodesix launched VeriStrat®, a serum...

Biodesix, Inc.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix provides physicians with tools for earlier d...

More Information about "Biodesix, Inc." on BioPortfolio

We have published hundreds of Biodesix, Inc. news stories on BioPortfolio along with dozens of Biodesix, Inc. Clinical Trials and PubMed Articles about Biodesix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biodesix, Inc. Companies in our database. You can also find out about relevant Biodesix, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record